Screening for sexual dysfunction in young cancer survivors
Official title: Stakeholder-Engaged Development and Evaluation of a Screening Approach for Sexual Dysfunction in Adolescent and Young Adult Patients With and Surviving Childhood Cancer
Run by University of Colorado, Denver · NCT05524610 · Data updated 2026-11-12
This study is trying out a new way to check for sexual problems in young cancer survivors aged 15-24 to help doctors better understand and support their needs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 24 Years |
| Sex | All |
| Enrollment | 205 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Drugs / interventions | Chemotherapy, immunotherapy |
| Locations | 2 sites (Aurora, Colorado and 1 other locations) |
| Status | Recruiting |
| Started | February 14, 2023 |
| Main results expected | March 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT05524610 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 15-24 who are currently receiving care or have survived childhood cancer.
✕Probably not a fit
Patients who are not within the age range of 15-24 or who have not been diagnosed with cancer before the age of 18 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop and implement a standardized screening approach for sexual dysfunction in adolescent and young adult (AYA) patients aged 15-24 who are survivors of childhood cancer. The approach will utilize the Patient Reported Outcome Measurement Information System (PROMIS) for Sexual Function and Satisfaction (SexFS) Brief, integrating feedback from both patients and medical providers. The study will pilot test this screening method across multiple clinics to improve the recognition and management of sexual dysfunction in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of sexual dysfunction in young cancer survivors, enhancing their quality of life.
How similar studies have gone: While there have been studies addressing sexual dysfunction in cancer survivors, this specific approach to screening in AYA patients is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Provision to sign and date the consent form. 2. Stated willingness to comply with all study procedures and be available for the duration of the study. 3. Be aged 15-24 years old at the time of enrollment 4. Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2) 5. Must have received cancer-directed therapy with at least one of the following: * Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy * Radiotherapy: any radiotherapy to treat the cancer diagnosis * Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery. 6. Cancer must have been diagnosed before the age of 18 years 7. Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program Exclusion Criteria An individual who meets any of the following criteria will be excluded from participation in this study: 1. Unable to read and speak English 2. Patients who did not receive cancer-directed therapy 3. Insufficient cognitive functioning to complete study measures, as determined by patient's 4. Participation in intervention development 5. Patient is at end of life or on hospice, as determined by primary oncologist 6. Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement 7. Patient is at end of life or on hospice, as determined by primary oncologist
Where it's running
-
Childrens Hospital Colorado
Aurora, Colorado, United States Recruiting -
University of Colorado Hospital
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Jenna Demedis — University of Colorado, Denver
- Study coordinator: Barbara Shepperd
- Email: barbara.shepperd@childrenscolorado.org
- Phone: 7207776819
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for childhood and young adult cancer patients
This study is creating a registry for young cancer patients to track their health and well-being over time and help improve future care.
-
Collecting data and specimens from pediatric cancer patients
This study is collecting samples and information from kids with cancer to see how their genes and tumor details can help find better treatments.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Cognitive training with real-time brain feedback for childhood medulloblastoma survivors
This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.